ArticleSensors (Basel, Switzerland)2025
Machine Learning-Based Risk Stratification for Sudden Cardiac Death Using Clinical and Device-Derived Data.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prediction of appropriate implantable cardioverter-defibrillator therapy using machine learning and routinely available clinical data.European heart journal. Digital health · 2026Article
- Machine learning prediction of sudden cardiac death incorporating multiple lipid markers: evidence from the Taiwan Chin Shan community cohort.Lipids in health and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sudden cardiac death (SCD) remains a major clinical challenge, with implantable cardioverter-defibrillators (ICDs) serving as the primary preventive intervention. Current patient selection guidelines rely on limited and imperfect risk markers. This study explores the potential of machine learning (ML) models to improve SCD risk prediction using tabular clinical data that include features derived from medical sensing devices such as electrocardiograms (ECGs) and ICDs. Several ML models, including tree-based models, Naive Bayes (NB), logistic regression (LR), and voting classifiers (VC), were trained on demographic, clinical, laboratory, and device-derived variables from patients who underwent ICD implantation at a Croatian tertiary center. The target variable was the activation of the ICD device (appropriate or inappropriate/missed), serving as a surrogate for high-risk SCD detection. Models were optimized for the F2-score to prioritize high-risk patient detection, and interpretability was achieved with post hoc SHAP value analysis, which confirmed known and revealed additional potential SCD predictors. The random forest (RF) model achieved the highest F2-score (F2-score 0.74, AUC-ROC 0.73), demonstrating a recall of 97.30% and meeting the primary objective of high true positive detection, while the VC classifier achieved the highest overall discrimination (F2-score 0.71, AUC-ROC 0.76). The predictive performance of multiple ML models, particularly the high recall they achieved, demonstrates the promising potential of ML to refine ICD patient selection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.